The Future of HIV-1 Therapeutics [electronic resource] Resistance Is Futile? / edited by Bruce E. Torbett, David S. Goodsell, Douglas D. Richman.

This volume thoroughly covers HIV-1 antiretrovirals currently in clinical use, together with their advantages and limitations. HIV-1 inhibitor resistance is discussed in detail, and critical assessments as to what will be required of future antiretrovirals in order to halt viral replication, reduce...

Full description

Bibliographic Details
Uniform Title:Current Topics in Microbiology and Immunology, 2196-9965 ; 389
Corporate Author: SpringerLink (Online service)
Other Authors: Torbett, Bruce E. (Editor)
Goodsell, David S. (Editor)
Richman, Douglas D. (Editor)
Language:English
Published: Cham : Springer International Publishing : Imprint: Springer, 2015.
Edition:1st ed. 2015.
Series:Current Topics in Microbiology and Immunology, 389
Subjects:
Medical microbiology.
Virology.
Diseases.
Online Access:
Springer English/International eBooks 2015 - Full Set: 2015 (Springer Link)
Variant Title:
Future of Hiv-1 Therapeutics: Resistance is Futile?
Format: Electronic eBook

MARC

LEADER 00000nam a22000003i 4500
001 ebs4530665e
003 EBZ
006 m o d ||||||
007 cr|unu||||||||
008 150422s2015 sz | o |||| 0|eng d
020 |z 9783319185170 
020 |a 9783319185187 (online) 
035 |a (EBZ)ebs4530665e 
040 |d EBZ 
042 |a msc 
050 4 |a QR46 
245 1 4 |a The Future of HIV-1 Therapeutics  |h [electronic resource]  |b Resistance Is Futile? /  |c edited by Bruce E. Torbett, David S. Goodsell, Douglas D. Richman. 
246 2 |a Future of Hiv-1 Therapeutics: Resistance is Futile? 
250 |a 1st ed. 2015. 
264 1 |a Cham :  |b Springer International Publishing :  |b Imprint: Springer,  |c 2015. 
490 1 |a Current Topics in Microbiology and Immunology,  |x 2196-9965 ;  |v 389 
505 0 |a HIV Therapy ­ Looking Towards the Future -- Computational challenges of structure-based approaches applied to HIV -- Nucleocapsid Protein: A Desirable Target For Future Therapies Against HIV-1 -- HIV-1 integrase multimerization as a therapeutic target -- Targeting HIV transcription: The quest for a functional cure -- Targeting the HIV RNA Genome: High-Hanging Fruit Only Needs a Longer Ladder -- HIV-1 Gag: An Emerging Target for Antiretroviral Therapy -- The Triple Threat of HIV-1 Protease Inhibitors -- Illustrations of the HIV Life Cycle. 
520 |a This volume thoroughly covers HIV-1 antiretrovirals currently in clinical use, together with their advantages and limitations. HIV-1 inhibitor resistance is discussed in detail, and critical assessments as to what will be required of future antiretrovirals in order to halt viral replication, reduce viral resistance, and alter the state of viral latency are presented. Experts at the forefront of HIV-1 research provide overviews of approaches from the fields of virology, chemical biology and structural biology for obtaining small molecule inhibitors that target viral regulatory and structural components at multiple points in the viral lifecycle. The individual chapters will appeal to scientists and clinicians alike. 
650 0 |a Medical microbiology. 
650 0 |a Virology. 
650 0 |a Diseases. 
700 1 |a Torbett, Bruce E.  |e editor.  |4 edt  |4 http://id.loc.gov/vocabulary/relators/edt 
700 1 |a Goodsell, David S.  |e editor.  |4 edt  |4 http://id.loc.gov/vocabulary/relators/edt 
700 1 |a Richman, Douglas D.  |e editor.  |4 edt  |4 http://id.loc.gov/vocabulary/relators/edt 
710 2 |a SpringerLink (Online service) 
773 0 |t Springer English/International eBooks 2015 - Full Set   |d Springer Nature 
776 0 8 |i Printed edition:  |z 9783319185194 
776 0 8 |i Printed edition:  |z 9783319185170 
776 0 8 |i Printed edition:  |z 9783319374505 
776 1 |t The Future of HIV-1 Therapeutics 
830 0 |a Current Topics in Microbiology and Immunology,  |x 2196-9965 ;  |v 389 
856 4 0 |y Access Content Online(from Springer English/International eBooks 2015 - Full Set)  |u https://ezproxy.msu.edu/login?url=https://link.springer.com/10.1007/978-3-319-18518-7  |z Springer English/International eBooks 2015 - Full Set: 2015